Article info

Download PDFPDF
Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications

Authors

  • Rafael Simó CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas) and Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autónoma de Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Cristina Hernández CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas) and Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autónoma de Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles
  • CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas) and Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autónoma de Barcelona, Barcelona, Spain Google scholar articles
  1. Correspondence to Dr Rafael Simó, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca, Pg. Vall d'Hebron 119-129, Barcelona 08035, Spain; rsimo{at}ir.vhebron.net
View Full Text

Citation

Simó R, Hernández C, on behalf of the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)*
Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications

Publication history

  • Accepted July 18, 2012
  • First published August 11, 2012.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.